News

GlobalData on MSN4d
FDA approves label updates for BMS’ CAR T cell therapies
Bristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates ...
Targeted Oncology1d
FDA Approves Updated Labels on CAR T-Cell Therapies, Eliminating REMS
FDA updates CAR T-cell therapy labels, easing monitoring requirements and expanding access for eligible patients in oncology.
CURE4d
FDA Approves CAR T Therapy Label Updates Across Various Blood Cancers
Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...
Bristol Myers, Gilead, J&J, Novartis win favorable FDA label updates for cell therapies
Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...
Earth.com1d
How do your cells know which parts of your body to build? Brilliant new tech is helping us find out
A fertilized egg somehow manages to build skin, brain, and blood cells within days. But how? New tech called LoxCode is ...
Neurons duped into delivering mitochondria to cancer cells found fueling tumor spread
University of South Alabama researchers report that neurons can transfer mitochondria directly to cancer cells, enhancing ...
Medical Dialogues2d
USFDA approves label updates for Bristol Myers Squibb 2 CAR T cell therapies
Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved label updates for ...
Contract Pharma4d
FDA Approves REMS Programs in BMS Cell Therapy Labels
Bristol Myers Squibb (BMS) received U.S. Food and Drug Administration (FDA) approval for label updates for its CAR T cell ...
Trumps drop ‘Made in the USA’ label for new phone and a debate ensues: How to define ‘made’?
The Trump family may be having second thoughts about that “Made in the USA” claim attached to its new Trump-branded phone, ...
Engineered protein can turn off tissue-damaging immune cells in autoimmune diseases
An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...
FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers
FDA approved label changes for Breyanzi and Abecma, easing access by reducing monitoring rules and eliminating REMS safety ...
Pharmabiz3d
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma: Princeton, New Jersey Saturday, June 28, 20 ...